Literature DB >> 25212550

Prevalence and prognostic significance of low QRS voltage among the three main types of cardiac amyloidosis.

Nicole B Cyrille1, Jeff Goldsmith2, Julissa Alvarez3, Mathew S Maurer4.   

Abstract

Low voltage is classically reported as an electrocardiographic (ECG) finding in cardiac amyloidosis (CA). We evaluated electrocardiograms to determine the prevalence of low voltage and its association with outcomes. Electrocardiograms in 200 patients with CA were reviewed. The presence of low voltage was assessed by all limb leads≤0.5 mV, all precordial leads≤1.0 mV, or Sokolow index≤.5 mV, and the association with time to adverse outcomes, including hospitalization, orthotopic heart transplant, and death, was assessed by the Cox proportional hazards model. Low voltage prevalence was 60% when using Sokolow index≤.5 mV, 34% by QRS amplitude≤0.5 mV in each limb lead, and 13% when ≤1.0 mV in each precordial lead with no differences in prevalence noted by the type of amyloid. Apart from atrial fibrillation and second-degree atrioventricular block being more common in wild type transthryretin cardiac amyloid (ATTRwt), the prevalence of ECG findings was similar among the 3 types of amyloid. Sokolow≤1.5 mV (HR 1.690; 95% CI of 1.069 to 2.672; p=0.0246) was independently associated with adverse outcomes. In conclusion, among the 3 main types of CA, the prevalence of low voltage is dependent on the method used for defining low voltage. Sokolow index≤1.5 mV indicated the highest prevalence and was associated with adverse outcomes in CA. Our data suggest that low voltage is a relatively late finding in CA and may not be useful for early identification.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25212550     DOI: 10.1016/j.amjcard.2014.07.026

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  38 in total

Review 1.  Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.

Authors:  Omar K Siddiqi; Frederick L Ruberg
Journal:  Trends Cardiovasc Med       Date:  2017-07-13       Impact factor: 6.677

2.  Electrocardiographic Impact of Myocardial Diffuse Fibrosis and Scar: MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Yuko Y Inoue; Bharath Ambale-Venkatesh; Nathan Mewton; Gustavo J Volpe; Yoshiaki Ohyama; Ravi K Sharma; Colin O Wu; Chia-Ying Liu; David A Bluemke; Elsayed Z Soliman; João A C Lima; Hiroshi Ashikaga
Journal:  Radiology       Date:  2016-10-13       Impact factor: 11.105

Review 3.  Cardiac amyloidosis: the great pretender.

Authors:  Claudio Rapezzi; Massimiliano Lorenzini; Simone Longhi; Agnese Milandri; Christian Gagliardi; Ilaria Bartolomei; Fabrizio Salvi; Mathew S Maurer
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

Review 4.  Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction.

Authors:  Wengen Chen; Van-Khue Ton; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2018-03-08       Impact factor: 2.931

Review 5.  Wild-type transthyretin cardiac amyloidosis (ATTRwt-CA), previously known as senile cardiac amyloidosis: clinical presentation, diagnosis, management and emerging therapies.

Authors:  Ilia G Halatchev; Jingsheng Zheng; Jiafu Ou
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

Review 6.  Recent advances in the noninvasive strategies of cardiac amyloidosis.

Authors:  Lei Zhao; Quan Fang
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

Review 7.  Transthyretin Cardiac Amyloidosis in Older Americans.

Authors:  Danielle L Brunjes; Adam Castano; Autumn Clemons; Jonah Rubin; Mathew S Maurer
Journal:  J Card Fail       Date:  2016-10-18       Impact factor: 5.712

Review 8.  Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis.

Authors:  Mathew S Maurer; Perry Elliott; Raymond Comenzo; Marc Semigran; Claudio Rapezzi
Journal:  Circulation       Date:  2017-04-04       Impact factor: 29.690

Review 9.  Noninvasive Identification of ATTRwt Cardiac Amyloid: The Re-emergence of Nuclear Cardiology.

Authors:  Mathew S Maurer
Journal:  Am J Med       Date:  2015-06-17       Impact factor: 4.965

Review 10.  Wild-Type Transthyretin Cardiac Amyloidosis: Novel Insights From Advanced Imaging.

Authors:  David L Narotsky; Adam Castano; Jonathan W Weinsaft; Sabahat Bokhari; Mathew S Maurer
Journal:  Can J Cardiol       Date:  2016-05-13       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.